10 March 2024>: Database Analysis
Potential of Gut Microbial Metabolites in Treating Osteoporosis and Obesity: A Network Pharmacology and Bioinformatics Approach
Md. Niaj Morshed 1ACEF* , Md. Rezaul Karim 12BE* , Reshmi Akter 1CDE , Safia Iqbal 1DF , Ramya Mathiyalagan 1CDF , Jong Chan Ahn 1BD , Deok Chun Yang 13CF , Joong Hyun Song 4CD , Se Chan Kang 1DFG* , Dong Uk Yang 15BFG*DOI: 10.12659/MSM.942899
Med Sci Monit 2024; 30:e942899
Table 6 Disease-related micro-biome, substrates, metabolites, and targets.
Micro-biome | Substrate | Metabolites | CID | Target | Disease |
---|---|---|---|---|---|
Unknown | 3,8,9-Trihydroxy-6H-benzo [c]chromen-6-one | Urolithin A | 5488186 | TP53 | OP |
Ellagic acid | |||||
Ginsenoside Rb1 | Compound K | 9852086 | |||
Tryptophan | Indole | 798 | AKT1 | ||
sp. | Geniposide | Genipin | 442424 | MAPK8 | |
Unknown | 3,8,9-Trihydroxy-6H-benzo [c]chromen-6-one | Urolithin A | 5488186 | TP53, G6PD | Obesity |
Ellagic acid | |||||
Ginsenoside Rb1 | Compound K | 9852086 | |||
sp. | Geniposide | Genipin | 442424 | MAPK8 | |
JS1 | Isoflavone | Equol | 91469 | IL18 | |
Linolic acid | 10-Oxo-11-octadecenoic acid | 10308378 | HMOX1 |